COL6A3 and neoplasm: In agreement with microarray data, COL6A3 expression was drastically reduced in all cell lines tested compared to matched tumors with cell line/tumor ratio of COL6A3 cDNA ranging from 0.03 to 1.5% (Fig. 5C).